Edward Kim

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. ncbi Complications associated with the posterolateral approach for pilon fractures
    Timothy Bhattacharyya
    Partners Orthopaedic Trauma Service, Massachusetts General Hospital, and Brigham and Women s Hospital, Boston, MA 02114, USA
    J Orthop Trauma 20:104-7. 2006
  2. ncbi A pilot study of quetiapine treatment of aggression due to traumatic brain injury
    Edward Kim
    Associate Professor of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 671 Hoes Lane, Piscataway, NJ 08855 1392, USA
    J Neuropsychiatry Clin Neurosci 18:547-9. 2006
  3. doi Does traumatic brain injury predispose individuals to develop schizophrenia?
    Edward Kim
    Department of Psychiatry, Robert Wood Johnson Medical School and Outcomes Research USA, Bristol Myers Squibb, Plainsboro, New Jersey 08536, USA
    Curr Opin Psychiatry 21:286-9. 2008
  4. doi Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis
    Edward Kim
    Bristol Myers Squibb, Plainsboro, New Jersey 08536, USA
    Clin Ther 31:836-48. 2009
  5. ncbi Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA Committee on Research)
    Edward Kim
    Bristol Myers Squibb Company, Neuroscience Medical Strategy, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA
    J Neuropsychiatry Clin Neurosci 19:106-27. 2007
  6. pmc One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis
    Edward Kim
    Bristol Myers Squibb, Plainsboro, NJ, USA
    BMC Psychiatry 11:6. 2011
  7. ncbi Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone
    Yonghua Jing
    Bristol Myers Squibb, Plainsboro, NJ 08536, USA
    J Med Econ 12:104-13. 2009
  8. ncbi Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents
    Dan W Haupt
    Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110 1093, USA
    Am J Psychiatry 166:345-53. 2009
  9. doi Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials
    John M Kane
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York 11004, USA
    Appl Health Econ Health Policy 7:109-19. 2009
  10. doi A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level
    Zhenchao Guo
    Bristol Myers Squibb, Wallingford, CT 06492, USA
    Prog Neuropsychopharmacol Biol Psychiatry 35:1326-32. 2011

Detail Information

Publications22

  1. ncbi Complications associated with the posterolateral approach for pilon fractures
    Timothy Bhattacharyya
    Partners Orthopaedic Trauma Service, Massachusetts General Hospital, and Brigham and Women s Hospital, Boston, MA 02114, USA
    J Orthop Trauma 20:104-7. 2006
    ..To review the complication rates of open reduction and internal fixation (ORIF) of tibial pilon fractures using the posterolateral approach...
  2. ncbi A pilot study of quetiapine treatment of aggression due to traumatic brain injury
    Edward Kim
    Associate Professor of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 671 Hoes Lane, Piscataway, NJ 08855 1392, USA
    J Neuropsychiatry Clin Neurosci 18:547-9. 2006
    ..Administration of quetiapine at doses of 25 to 300 mg daily was efficacious and well-tolerated in reducing irritability and aggression resulting from TBI, with an associated improvement in cognitive functioning...
  3. doi Does traumatic brain injury predispose individuals to develop schizophrenia?
    Edward Kim
    Department of Psychiatry, Robert Wood Johnson Medical School and Outcomes Research USA, Bristol Myers Squibb, Plainsboro, New Jersey 08536, USA
    Curr Opin Psychiatry 21:286-9. 2008
    ..Schizophrenia is a psychotic disorder commonly attributed to the interaction of genetic vulnerability and environmental events, yet its relationship with traumatic brain injury has not been systematically reviewed...
  4. doi Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis
    Edward Kim
    Bristol Myers Squibb, Plainsboro, New Jersey 08536, USA
    Clin Ther 31:836-48. 2009
    ....
  5. ncbi Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA Committee on Research)
    Edward Kim
    Bristol Myers Squibb Company, Neuroscience Medical Strategy, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA
    J Neuropsychiatry Clin Neurosci 19:106-27. 2007
    ..Larger multicenter prospective studies using standardized diagnostic instruments are needed to further clarify the nosology, risk factors, and clinical course of these disorders. Specific directions for research are provided...
  6. pmc One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis
    Edward Kim
    Bristol Myers Squibb, Plainsboro, NJ, USA
    BMC Psychiatry 11:6. 2011
    ..This study compared 1-year risk of psychiatric hospitalization and treatment costs in commercially insured patients with bipolar disorder, treated with aripiprazole, ziprasidone, olanzapine, quetiapine or risperidone...
  7. ncbi Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone
    Yonghua Jing
    Bristol Myers Squibb, Plainsboro, NJ 08536, USA
    J Med Econ 12:104-13. 2009
    ..This study compared healthcare costs in patients treated with a mood stabilizer and adjunctive aripiprazole versus adjunctive olanzapine, quetiapine, risperidone or ziprasidone...
  8. ncbi Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents
    Dan W Haupt
    Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110 1093, USA
    Am J Psychiatry 166:345-53. 2009
    ....
  9. doi Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials
    John M Kane
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York 11004, USA
    Appl Health Econ Health Policy 7:109-19. 2009
    ..Since their introduction, second-generation antipsychotics (SGAs) have become the drugs of choice for the treatment of schizophrenia. However, recent findings have questioned the benefits of SGAs over first-generation antipsychotics (FGAs)...
  10. doi A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level
    Zhenchao Guo
    Bristol Myers Squibb, Wallingford, CT 06492, USA
    Prog Neuropsychopharmacol Biol Psychiatry 35:1326-32. 2011
    ..One of the limitations of a claims data analysis is the lack of information on potential confounders such as ethnicity and weight...
  11. ncbi The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia
    Jonathan M Meyer
    Department of Psychiatry, VA San Diego Healthcare System and University of California, San Diego, CA, USA
    J Clin Psychiatry 70:318-25. 2009
    ..Race is strongly associated with risk for metabolic dysfunction, but there is limited prospective data concerning the impact of race on antipsychotic metabolic outcomes among patients with schizophrenia...
  12. ncbi Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey
    Edward Kim
    Bristol Myers Squibb, Plainsboro, NJ, USA
    J Med Econ 13:185-92. 2010
    ..Assess the association of schizophrenia patients' perceived copayment burden with medication adherence and outcomes...
  13. ncbi Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis
    Del D Miller
    Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA 52242 1000, USA
    J Clin Psychiatry 68:1901-6. 2007
    ..To comparatively assess the incidence of tardive dyskinesia in patients with schizophrenia receiving either aripiprazole or haloperidol...
  14. ncbi Personalized treatment with atypical antipsychotic medications
    Edward Kim
    Associate Director, Outcomes Research USA, Global Epidemiology and Outcomes Research, Bristol Myers Squibb Company, Plainsboro, New Jersey, USA
    Adv Ther 24:721-40. 2007
    ....
  15. pmc A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States
    Timothy Juday
    Bristol Myers Squibb Research and Development, Plainsboro, NJ, USA
    AIDS Care 23:1154-62. 2011
    ..39; p<0.001). HIV treatment persistence was longer with NNRTI-based regimens than PI-based regimens. The fixed-dose regimen of once-daily efavirenz/emtricitabine/tenofovir had the lowest risk of discontinuation...
  16. doi Factors associated with complete adherence to HIV combination antiretroviral therapy
    Timothy Juday
    Bristol Myers Squibb, Plainsboro, NJ, USA
    HIV Clin Trials 12:71-8. 2011
    ..To assess factors associated with adherence, particularly pill burden, to combination antiretroviral therapy (cART) using multivariate models...
  17. ncbi Divalproex in the management of neuropsychiatric complications of remote acquired brain injury
    Edward Kim
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, 671 Hoes Lane, Piscataway, NJ 08855 1392, USA
    J Neuropsychiatry Clin Neurosci 14:202-5. 2002
    ..5. This is the largest postacute case series reported. It demonstrates that divalproex sodium is well tolerated and effective in reducing a broad range of neurobehavioral symptoms in psychiatric patients with a remote history of ABI...
  18. ncbi Agitation, aggression, and disinhibition syndromes after traumatic brain injury
    Edward Kim
    University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ, USA
    NeuroRehabilitation 17:297-310. 2002
    ..Management of TBI-related aggression may involve pharmacological, environmental, and psychotherapeutic strategies that incorporate caregiver training and support...
  19. ncbi The use of newer anticonvulsants in neuropsychiatric disorders
    Edward Kim
    Robert Wood Johnson Medical School, The University of Medicine and Dentistry of New Jersey, Piscataway 08854, USA
    Curr Psychiatry Rep 4:331-7. 2002
    ..Less consistent data are available for other medications. Further prospective studies are warranted to examine the use of these medications in neuropsychiatric populations...
  20. ncbi Efficacy of the team solutions program for educating patients about illness management and treatment
    Betty Vreeland
    University Behavioral HealthCare UBHC and Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey UMDNJ, Piscataway, New Jersey 08855, USA
    Psychiatr Serv 57:822-8. 2006
    ..Team Solutions was chosen for study because it is available over the Internet and other venues at no cost and is used by mental health agencies across the United States and Canada...
  21. ncbi Effect of inadequate response to treatment in patients with depression
    Russell L Knoth
    Bristol Myers Squibb, Plainsboro, NJ, USA
    Am J Manag Care 16:e188-96. 2010
    ..To assess the effects of inadequate response to antidepressant treatment on healthcare resource utilization and on work productivity in patients diagnosed as having major depressive disorder (MDD)...
  22. pmc Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment
    Timothy Juday
    Research and Development, Bristol Myers Squibb Co, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA
    J Gen Intern Med 26:239-44. 2011
    ..This study aimed to assess adherence to treatment guideline-recommended monitoring of CHB patients not receiving antiviral treatment and to identify predictors of laboratory monitoring and subsequent initiation of antiviral therapy...